Citations

Clear

1053 citation(s) found for "Andre, F".

Cardioprotection: emerging pharmacotherapy
Gumina, Richard J. , Gross, Garrett J., Jahangir, Arshad , Terzic, André

Mayo Clinic

Expert Opinion on Pharmacotherapy | May 5, 2005 | Volume: 2 | Issue: 5 | Pages: 739-752

10.1517/14656566.2.5.739 | PMID 11336619 Get It

Differential Effects of Theophylline on Sympathetic Excitation, Hemodynamics, and Breathing in Congestive Heart Failure
Reiter, Hartwig, Lüthje, Lars , Delekat, André, Grunewald, R. Willi, Andreas, Stefan , Hasenfuß, Gerd , Somers, Virend K.

Mayo Clinic

Circulation | October 5, 2004 | Volume: 110 | Issue: 15 | Pages: 2157-2162

10.1161/01.cir.0000144356.39262.16 | PMID 15466632 Get It

Background— Patients with heart failure have high levels of central sympathetic outflow and also have a high prevalence of sleep-related breathing disorders, predominantly central sleep apnea. The options for treating central sleep apnea in heart failure are limited and include theophylline. Whether theophylline alters sympathetic activity in heart failure patients is not known. Methods and Results— Using a single-blinded, randomized, placebo-controlled study design, we investigated the sympathetic, hemodynamic, neurohumoral, and ventilatory effects of theophylline in patients with congestive heart failure compared with healthy control subjects closely matched for age, sex, and body mass index. Theophylline increased muscle sympathetic nerve activity and lowered transcutaneous CO 2 in the control subjects but only lowered transcutaneous CO 2 in the heart failure patients. Theophylline nearly doubled plasma renin concentration in both the healthy subjects ( P <0.01) and the heart failure patients ( P <0.02). Conclusions— Our study shows that in heart failure patients, there are differential effects of theophylline: in contrast to healthy subjects, theophylline does not increase sympathetic activity in heart failure, whereas increases in plasma renin and ventilation are still evident. These novel findings may have important implications for understanding the potential harmful and beneficial effects of theophylline and related substances in heart failure patients.
Molecular Prognostication for Soft Tissue Sarcomas: Are We Ready Yet?
Oliveira, André M. , Fletcher, Christopher D.�M.

Mayo Clinic

Journal of Clinical Oncology | September 14, 2004 | Volume: 22 | Issue: 20 | Pages: 4031-4034

10.1200/jco.2004.06.025 | PMID 15364964 Get It

Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest
Sengupta, Sagar , Robles, Ana I. , Linke, Steven P. , Sinogeeva, Natasha I., Pedeux, Rémy , Ward, Irene M., Celeste, Arkady, Nussenzweig, André , Halazonetis, Thanos D. , Harris, Curtis C. , Zhang, Ran , Chen, Junjie

Mayo Clinic

The Journal of Cell Biology | September 13, 2004 | Volume: 166 | Issue: 6 | Pages: 801-813

10.1083/jcb.200405128 | PMID 15364958 Get It

Bloom's syndrome is a rare autosomal recessive genetic disorder characterized by chromosomal aberrations, genetic instability, and cancer predisposition, all of which may be the result of abnormal signal transduction during DNA damage recognition. Here, we show that BLM is an intermediate responder to stalled DNA replication forks. BLM colocalized and physically interacted with the DNA damage response proteins 53BP1 and H2AX. Although BLM facilitated physical interaction between p53 and 53BP1, 53BP1 was required for efficient accumulation of both BLM and p53 at the sites of stalled replication. The accumulation of BLM/53BP1 foci and the physical interaction between them was independent of γ-H2AX. The active Chk1 kinase was essential for both the accurate focal colocalization of 53BP1 with BLM and the consequent stabilization of BLM. Once the ATR/Chk1- and 53BP1-mediated signal from replicational stress is received, BLM functions in multiple downstream repair processes, thereby fulfilling its role as a caretaker tumor suppressor.
Human Endothelial Progenitor Cells Tolerate Oxidative Stress Due to Intrinsically High Expression of Manganese Superoxide Dismutase
He, Tongrong , Peterson, Timothy E., Holmuhamedov, Ekhson , Caplice, Noel M. , Oberley, Larry W., Katušić, Zvonimir S. , Terzic, André

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | August 20, 2004 | Volume: 24 | Issue: 11 | Pages: 2021-2027

10.1161/01.atv.0000142810.27849.8f | PMID 15319267 Get It

Objective— Endothelial progenitor cells (EPCs) display a unique aptitude to promote angiogenesis and restore endothelial function of injured vessels. How progenitor cells can execute a regenerative program in the unfavorable environment of injury/inflammation-induced oxidative stress is poorly understood. We hypothesized that EPCs are resistant to oxidative stress and that this resistance is due to high expression and activity of antioxidant enzymes. Methods and Results— EPCs outgrown from human blood of healthy subjects demonstrated a marked resistance to cytotoxic effect of LY83583 (an generator), tumor necrosis factor-α, and serum depletion. LY83583 inhibited in vitro tube formation by human umbilical vein endothelial cells (HUVECs) and human coronary artery endothelial cells (CAECs), but not by EPCs. Compared with HUVECs and CAECs, EPCs exhibited ≈3- to 4-fold higher expression and activity of manganese superoxide dismutase (MnSOD), but not copper zinc superoxide dismutase (CuZnSOD) or catalase. The antioxidant profile in EPCs was associated with preservation of the mitochondrial network when exposed to LY83583. Moreover, cytotoxic effects of LY83583 on CAECs and HUVECs were reversed by adenoviral overexpression of MnSOD. Conclusions— Human EPCs are resistant to oxidative stress. High intrinsic expression of MnSOD is a critical mechanism protecting EPCs against oxidative stress.
53BP1 is required for class switch recombination
Ward, Irene M., Reina‐San‐Martin, Bernardo , Olaru, Alexandru, Minn, Kay, Tamada, Koji , Lau, Julie S., Cascalho, Marília , Nussenzweig, André , Livák, Ferenc , Nussenzweig, Michel C. , Nussenzweig, André , Chen, Lieping , Chen, Junjie

Mayo Clinic

The Journal of Cell Biology | May 24, 2004 | Volume: 165 | Issue: 4 | Pages: 459-464

10.1083/jcb.200403021 | PMID 15159415 Get It

53BP1 participates early in the DNA damage response and is involved in cell cycle checkpoint control. Moreover, the phenotype of mice and cells deficient in 53BP1 suggests a defect in DNA repair (Ward et al., 2003b). Therefore, we asked whether or not 53BP1 would be required for the efficient repair of DNA double strand breaks. Our data indicate that homologous recombination by gene conversion does not depend on 53BP1. Moreover, 53BP1-deficient mice support normal V(D)J recombination, indicating that 53BP1 is not required for “classic” nonhomologous end joining. However, class switch recombination is severely impaired in the absence of 53BP1, suggesting that 53BP1 facilitates DNA end joining in a way that is not required or redundant for the efficient closing of RAG-induced strand breaks. These findings are similar to those observed in mice or cells deficient in the tumor suppressors ATM and H2AX, further suggesting that the functions of ATM, H2AX, and 53BP1 are closely linked.
Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease
Trushina, Eugenia , Heldebrant, Michael P., Pérez-Terzic, Carmen, Bortolon, Ryan, Kovtun, Irina V. , Badger, John D., Estévez, Álvaro G. , Windebank, Anthony J. , Dyer, Roy B. , Yao, Janet , McMurray, Cynthia T. , Terzic, André , Trushina, Eugenia

Mayo Clinic

Proceedings of the National Academy of Sciences | October 14, 2003 | Volume: 100 | Issue: 21 | Pages: 12171-12176

10.1073/pnas.2034961100 | PMID 14527999 Get It

There has been a longstanding debate regarding the role of proteolysis in Huntington's disease. The toxic peptide theory posits that N-terminal cleavage fragments of mutant Huntington's disease protein [mutant huntingtin (mhtt)] enter the nucleus to cause transcriptional dysfunction. However, recent data suggest a second model in which proteolysis of full-length mhtt is inhibited. Importantly, the two competing theories differ with respect to subcellular distribution of mhtt at initiation of toxicity: nuclear if cleaved and cytoplasmic in the absence of cleavage. Using quantitative single-cell analysis and time-lapse imaging, we show here that transcriptional dysfunction is “downstream” of cytoplasmic dysfunction. Primary and reversible toxic events involve destabilization of microtubules mediated by full-length mhtt before cleavage. Restoration of microtubule structure by taxol inhibits nuclear entry and increases cell survival.
Phosphotransfer networks and cellular energetics
Dzeja, Petras P. , Terzic, André

Mayo Clinic

Journal of Experimental Biology | May 19, 2003 | Volume: 206 | Issue: 12 | Pages: 2039-2047

10.1242/jeb.00426 | PMID 12756286 Get It

SUMMARY Precise coupling of spatially separated intracellular ATP-producing and ATP-consuming processes is fundamental to the bioenergetics of living organisms, ensuring a fail-safe operation of the energetic system over a broad range of cellular functional activities. Here, we provide an overview of the role of spatially arranged enzymatic networks, catalyzed by creatine kinase,adenylate kinase, carbonic anhydrase and glycolytic enzymes, in efficient high-energy phosphoryl transfer and signal communication in the cell. Studies of transgenic creatine kinase and adenylate kinase deficient mice, along with pharmacological targeting of individual enzymes, have revealed the importance of near-equilibrium reactions in the dissipation of metabolite gradients and communication of energetic signals to distinct intracellular compartments,including the cell nucleus and membrane metabolic sensors. Enzymatic capacities, isoform distribution and the dynamics of net phosphoryl flux through the integrated phosphotransfer systems tightly correlate with cellular functions, indicating a critical role of such networks in efficient energy transfer and distribution, thereby securing the cellular economy and energetic homeostasis under stress.
Inhibition of Both Na/H and Bicarbonate-Dependent Exchange is Required to Prevent Recovery of Intracellular pH in Single Cardiomyocytes Exposed to Metabolic Stress
Serrano, Oscar K. , Jovanović, Aleksandar , Terzic, André

Mayo Clinic

Bioscience Reports | March 15, 2003 | Volume: 19 | Issue: 2 | Pages: 99-107

10.1023/a:1020158426538 | PMID 10888472 Get It

Although tight regulation of intracellular pH (pHi) is critical for the survival under stress, paradoxically a slowed recovery of pHi under hypoxic injury may be cardioprotective. In this study, we investigated the recovery of pHi after hypoxia-induced intracellular acidosis in cardiomyocytes loaded with the H+-sensitive dye SNARF-1. Exposure of single cardiomyocytes to 2,4-dinitrophenol (DNP), an inhibitor of mitochondrial oxidative phosphorylation, induced significant intracellular acidification. However, within 10–12 min upon removal of DNP, cardiomyocytes restituted their intracellular H+ concentration. The presence either of 5-N-ethyl-N-isopropylamiloride (EIPA) an inhibitor of Na/H antiporter, or 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS), an inhibitor of bicarbonate-dependent exchange, did not modify the cellular response to DNP. But, combined use of EIPA and DIDS prevented the restitution of intracellular pH following removal of DNP. This study, thus, demonstrated, for the first time, that blockade of both Na/H and bicarbonate-dependent exchange is necessary and sufficient to maintain the hypoxia-induced intracellular acidification. Therefore, concomitant blockade of both pH-regulating mechanisms deserves to be further considered as a novel strategy against hypoxia-reoxygenation injury in the heart.
Structural Adaptation of the Nuclear Pore Complex in Stem Cell–Derived Cardiomyocytes
Pérez-Terzic, Carmen, Behfar, Atta , Méry, Annabelle, Deursen, Jan M. A. van, Pucéat, Michel , Terzic, André , Behfar, Atta

Mayo Clinic

Circulation Research | March 6, 2003 | Volume: 92 | Issue: 4 | Pages: 444-452

10.1161/01.res.0000059415.25070.54 | PMID 12600892 Get It

Macromolecules are transported in and out of the nucleus through nuclear pores. It is poorly understood how these megadalton conduits support nucleocytoplasmic traffic during genetic reprogramming associated with cell commitment to a specific lineage. Murine embryonic stem cells were differentiated into cardiomyocytes within embryoid bodies, and contracting cells expressing myocardial-specific proteins were isolated from the mesodermal layer. Compared with postmitotic cardiac cells from heart muscle, these proliferative and differentiating stem cell–derived cardiomyocytes demonstrated a significantly lower density of nuclear pores. At nanoscale resolution, the pore channel was commonly unoccupied in heart muscle–isolated cardiac cells, yet a dense material, presumably the central transporter, protruded toward the cytosolic face of the nuclear pore complex in stem cell–derived cardiomyocytes. Stem cell–derived cardiac cells distributed the nuclear transport factor Ran in the nucleus, decreased the number of spare nuclear pore complexes from the cytosolic annulate lamellae reservoir, and expressed a set of nucleoporins, NUP214, NUP358, NUP153, and p62, involved in nuclear transport. Stem cell–derived cardiomyocytes secured transport of nuclear constitutive proteins, cardiogenic transcription factors, and cell cycle regulators, including the prototypic histone H1, myocyte enhancer binding factor 2, and p53. Thus, differentiating stem cell–derived cardiomyocytes undergo structural adaptation and mobilize nuclear transport regulators in support of nucleocytoplasmic communication during commitment to mature cardiac lineage.